<DOC>
	<DOCNO>NCT01839149</DOCNO>
	<brief_summary>This study evaluate use oxytocin , give nasal spray , treatment high frequency episodic migraine chronic migraine .</brief_summary>
	<brief_title>TI-001 ( Intranasal Oxytocin ) Treatment High Frequency Episodic Migraine Chronic Migraine</brief_title>
	<detailed_description />
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Oxytocin</mesh_term>
	<criteria>1 . Men woman , age 18 65 year primary diagnosis high frequency episodic migraine chronic migraine . 1 . Known allergy oxytocin 2 . History addictive behavior ( eg , alcoholism , drug abuse ) severe mood disorder 3 . History clinically significant , functionally impair cardiovascular pulmonary disease disease might confound study result 4 . Have basilar hemiplegic migraine 5 . Have substantial cognitive memory impairment due cause ( eg , Alzheimer 's dementia ) 6 . Have nasal obstruction due cause 7 . Are pregnant breast feed 8 . Require ongoing use steroidal nonsteroidal antiinflammatory drug 9 . Are unable unwilling provide inform consent follow study procedure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Refractory Chronic Migraine</keyword>
	<keyword>Medically Intractable Chronic Migraine</keyword>
	<keyword>Oxytocin</keyword>
	<keyword>Intranasal oxytocin</keyword>
</DOC>